Cannabichromene
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cannabichromene, covering 2025-07-28 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Cannabichromene Safety in Rheumatoid Arthritis [Phase 1, Phase 2]